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Abstract
RNA polymerase II synthesizes a diverse set of transcripts including both protein-coding and non-coding RNAs. One major
difference between these two classes of transcripts is the mechanism of termination. Messenger RNA transcripts terminate
downstream of the coding region in a process that is coupled to cleavage and polyadenylation reactions. Non-coding
transcripts like Saccharomyces cerevisiae snoRNAs terminate in a process that requires the RNA–binding proteins Nrd1,
Nab3, and Sen1. We report here the transcriptome-wide distribution of these termination factors. These data sets derived
from in vivo protein–RNA cross-linking provide high-resolution definition of non-poly(A) terminators, identify novel genes
regulated by attenuation of nascent transcripts close to the promoter, and demonstrate the widespread occurrence of
Nrd1-bound 39 antisense transcripts on genes that are poorly expressed. In addition, we show that Sen1 does not cross-link
efficiently to many expected non-coding RNAs but does cross-link to the 39 end of most pre–mRNA transcripts, suggesting
an extensive role in mRNA 39 end formation and/or termination.
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Introduction
Early in each transcription cycle RNA polymerase II (Pol II) can
follow one of two paths; terminate early through the Nrd1-Nab3-
Sen1 pathway or continue on to form longer, potentially coding
transcripts [1,2]. Yeast Nrd1, Nab3 and Sen1 are part of a
complex [3] that interacts both with the phosphorylated Pol II C-
terminal domain (CTD) [4–6], and with specific sequences in the
nascent transcript [7,8]. If this set of protein-protein and protein-
RNA contacts is sufficient, the Nrd1-Nab3-Sen1 complex directs
Pol II termination and couples this to processing of the nascent
transcript by TRAMP and the nuclear exosome [9,10]. In
addition to directing termination of snoRNAs and cryptic unstable
transcripts (CUTs) the Nrd1-Nab3-Sen1 pathway directs prema-
ture termination of several pre-mRNA transcripts including
NRD1, IMD2, URA2, URA8, and ADE12 [11–15]. The mechanism
by which the Nrd1-Nab3-Sen1 complex leads to Pol II
termination is unknown but involves recognition of specific
terminator sequences by Nrd1 and Nab3 [7,8,16] and the putative
helicase activity of Sen1 [16,17].
In this study we have used a recently developed in vivo cross-
linking approach [18] to derive high-resolution transcriptome-
wide maps of binding sites for Nrd1, Nab3, Sen1, and the Pol II
subunit Rpb2. This approach yields a more precise picture of
known Nrd1 and Nab3 binding sites on snoRNA, CUT and
mRNA targets and reveals a set of previously unknown Nrd1
binding sites both on the 59 ends of mRNAs and on 39 antisense
transcripts. Surprisingly, Sen1 does not cross-link at many of these
Nrd1-Nab3 binding sites. Instead, we observe Sen1 cross-linking
on mRNA transcripts, particularly at the 39 end suggesting a
potential role for Sen1 in mRNA 39 end formation through the
cleavage and polyadenylation pathway.
Results
The Photoactivatable-Ribonucleoside-Enhanced Crosslinking
and Immunoprecipitation (PAR-CLIP) technique [18] was adapted
to yeast (Materials and Methods). Briefly, cells are grown in the
presence of 4-thiouracil which is incorporated into RNA. UV irra-
diation at 365 nm results in high-efficiency covalent cross-linking of
RNA to protein [18]. We then purify the tagged protein under
denaturing conditions [19], prepare cDNA libraries to the cova-
lently attached RNAs and sequence the libraries. As previously
reported, reverse transcription of the cross-linked 4-thiouracil leads
to a characteristic T to C transition in the cDNA sequence [18].
Among all single-base changes observed in the sequences we
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approximately 90% were T to C transitions; about 10-fold greater
than the number expected for random errors. Data analysis was
limited to sequences containing a single base change from the
reference sequence thus pinpointing the site of cross-linking in these
sequences.
In all, we report sequence data for five libraries (Table S1)
including data for Nrd1, Nab3, Sen1 and the RNA Pol II subunit
Rpb2. Similar datasets have recently been reported by the
Tollervey lab [20] who crosslinked Nrd1, Nab3 and Trf4 using
an alternative UV cross-linking procedure (CRAC) [21]. The
Nrd1 and Nab3 cross-linking datasets obtained by PAR-CLIP and
CRAC are very similar. In both cases the majority of cross-links
occur on Pol II transcripts with snoRNA transcripts the most
abundant. Pol III transcripts are also cross-linked to Nrd1 and
Nab3 and Wlotzka et al. provide evidence for a role for Nrd1 in
processing pre-tRNAs [20]. A minor amount of Nrd1, Nab3 and
Sen1 cross-links to ribosomal RNA and we have not pursued
this further. Our cross-linking of Nrd1, Nab3, Sen1 and Rpb2
to snoRNA, snRNA, and tRNA will be discussed in another
publication [22].
To validate the PAR-CLIP procedure in yeast we identified
Nrd1 and Nab3 binding sites downstream of the SNR13 gene
(Figure S1) with a peak of cross-linking within a region containing
termination elements identified through genetic analysis [7,8]. In
addition, Figure S1 shows multiple Nrd1 and Nab3 binding sites in
the upstream region of the Nrd1 gene, an observation consistent
with our previous work showing that multiple mutations were
required to inactivate autoregulation of Nrd1 expression [11].
While we cannot say with certainty whether the extent of cross-
linking is exhaustive, we observe cross-linking at all previously
observed Nrd1 and Nab3 binding sites including those on
snoRNAs, snRNAs, attenuated mRNA transcripts and CUTs.
RNA binding is not required for Nrd1 chromatin
association
Previous studies have shown that Nrd1 and Nab3 are present on
chromatin and localized to genes that are regulated by Nrd1 and
Nab3 [4,6,9,11,23]. Because the Nrd1 complex interacts both with
the nascent transcript and with Pol II, it is not clear which
interaction is primarily responsible for chromatin binding. We
have analyzed Nrd1 and Nab3 interactions with both chromatin
and RNA. Figure 1 shows a comparison of ChIP-chip of Nrd1
compared to Nrd1 and Nab3 PAR-CLIP. Two tracks displaying
Pol II subunits Rpb2 and Rpb3 are shown for reference, as they
are both part of the catalytic core and thus are expected to co-
localize. All five data sets were obtained from cells growing in log
phase. Nrd1 and Pol II co-localize by ChIP at both the RPS5 and
SNR3 genes (Figure 1). Nab3 ChIPs similarly to Nrd1 (not shown).
In contrast, Nrd1 and Nab3 cross-link to RNA in a subset of the
major Nrd1 ChIP peaks. For example, in Figure 1 we observe
efficient cross-linking of Nrd1 and Nab3 to SNR3 transcripts but
not to RPS5 transcripts. Genomewide, the Nab3 RNA cross-
linking pattern is nearly identical to Nrd1 (Wilcoxon rank sum
p,10
28). Similar specificity of Nrd1 RNA cross-linking is seen at
other highly expressed genes. Among the top 100 Nrd1 ChIP
peaks determined using CisGenome [24] are ten other ribosomal
protein genes, none of which are among the top 100 Nrd1 PAR-
CLIP peaks (not shown). We conclude that Nrd1, Nab3, and
presumably Sen1 are able to enter the early Pol II elongation
complex independent of RNA binding and monitor the nascent
RNA for appropriate binding sites.
Nrd1 and Nab3 binding sites
Figure 2A shows the logos [25] of motifs in a representative
MEME [26] trial using sequences of 40 nt centered on the most
prominent RNA cross-link (T to C) sites. Nrd1 cross-links reveal a
consensus sequence UGUAG with an E-value of 1.8e
225 where
the underlined U is the most frequently cross-linked residue. The
top-scoring motif in the Nab3 pool is a consensus sequence
GNUCUUGU. The E-value under the same conditions as the
Nrd1 analysis is much higher (6.7e
3) indicating that this motif is
not nearly as constrained. These motifs are nearly identical to the
GUA[A/G] and UCUU sequences that we previously identified
using genetic and biochemical approaches [7,8] and contain many
of the over-represented 4 mer sequences in sequences that cross-
link to Nrd1 and Nab3 by the CRAC protocol with 254 nm UV
irradiation [20]. Our Nab3 motif is very similar to the
UUCUUGUW motif identified by microarray analysis of RNA
co-purified with Nrd1 in the absence of cross-linking and under
non-denaturing conditions [27]. No conserved motifs were
observed for Sen1 and Rpb2, consistent with their presumed
roles as enzymes that interact non-specifically with RNA.
About 50% of the Nrd1 and Nab3 cross-linked regions overlap.
This is not surprising given that Nrd1 and Nab3 are known to
dimerize in vivo and in vitro [7,28]. The second most significant
motif, as determined in MEME, in the Nrd1 set corresponded to
the top rated motif in the Nab3 analysis and vice versa, again
suggesting that Nrd1 and Nab3 binding sites are located close to
each other.
In Figure 2B we show that Nrd1 cross-linking sites are clustered.
The 50 Nrd1 cross-linked sites with the most reads (as determined
by MochiView [29]) were used as an anchor in this plot. The
number of cross-links observed as a function of the distance from
the top 50 cross-linked sites is increased in a window approxi-
mately 30 nt upstream and downstream of the central Nrd1 cross-
link. No similar clustering of Nab3 cross-linking sites was observed
indicating that most Nab3 binding regions do not contain multiple
motifs. Together, these results suggest that these strong Nrd1
binding sites have been selected to bind multiple Nrd1 proteins,
a result consistent with our in vitro binding experiments suggest-
ing that the Nrd1-Nab3 complex binds cooperatively to RNA
targets [7].
Author Summary
Transcription in eukaryotes is widespread including both
protein-coding transcripts and an increasing number of
non-coding RNAs. Here we present the results of transcrip-
tome-wide mapping of a set of yeast RNA–binding proteins
that control expression of some protein-coding genes and a
number of novel non-coding RNAs. The yeast Nrd1-Nab3-
Sen1 pathway is required for termination and exosome-
mediated processing of non-coding RNA polymerase II
transcripts. Our data show that these components bind
unexpected targets including a large number of antisense
transcripts originating from the 39 end of genes that are
poorly expressed in the sense direction. We also show that
Sen1 helicase, involved in termination of non-coding RNAs,
is also present at the 39 end of mRNAs, suggesting a more
fundamental role in transcription termination. Mis-regula-
tion of transcriptionis the underlyingcause of manydisease
states. For example, mutation of the human Sen1 gene,
senataxin, causes a range of neurodegenerative disorders.
Understanding the roles of yeast RNA–binding proteins in
controlling termination of coding and non-coding RNAs will
be usefulin deciphering the mechanism of theseproteins in
human cells.
Yeast RNA-Binding Termination Factors
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For both Nrd1 and Nab3 data sets binding sites on snoRNA
transcripts were among the most extensively cross-linked (Tables S2
and S3). At most snoRNAs we observed a peak of Nrd1 binding
downstream of the mature 39 end of the RNA consistent with the
previously demonstrated role in termination [16]. Figure 3A and 3B
shows the distribution of cross-linked sequences downstream of
SNR3 and SNR13. Nrd1 binds predominantly downstream of
the mature RNA, while Rpb2 cross-links across the transcript.
Surprisingly, Sen1 cross-links efficiently to some snoRNA tran-
scripts like snR3, but not to others, like snR13. This is an
unexpected result considering previous experiments showing that at
bothofthesesnoRNAgenesPolIIreadsthroughtheterminatorina
sen1 mutant at the non-permissive temperature [16] and both genes
have Sen1 present on chromatin as determined by ChIP [30,31].
Sen1 binds poorly to attenuated mRNA transcripts
We have previously shown that Nrd1 regulates its own
expression by binding to sites in the 59 end of its mRNA and
directing premature termination. This attenuation mechanism
requires the function of Nrd1, Nab3 and Sen1 [16]. The Nrd1-
Nab3-Sen1 pathway is also required for the formation of
attenuated transcripts from the IMD2 promoter [12]. We were
therefore surprised that Sen1 does not crosslink as efficiently to
NRD1 or IMD2 mRNA as it does to other mRNAs, for example
CCW12 (Figure 3C and 3D and Figure S2).
Nrd1 binds preferentially to unstable intergenic ncRNAs
Of the top 300 Nrd1 and Nab3 peaks, 93 and 54, respectively,
overlap with CUTs (out of 925 annotated CUTS [32,33]). By
contrast, only 23 (Nrd1) and 8 (Nab3) peaks overlap with SUTs
(stable unannotated transcripts, out of 847 annotated SUTs
[32,33]). This preference for binding unstable transcripts is
consistent with Nrd1-Nab3 binding being a key feature that
distinguishes between CUTs and SUTs [20]. In Figure S3 we
show that Nrd1 binds to several known CUTs. The Nrd1 cross-
linking sites on CUT transcripts tend to be located toward the 59
end, a position in which Nrd1 and Nab3 may direct the observed
range of termination sites downstream of these binding sites
[9,10,34]. The observation that some CUTs are not bound by
Nrd1 is somewhat surprising. In Figure S3 we observe that some
CUTs and SUTs are not expressed under our experimental
conditions as shown by the lack of cross-linking to Rpb2.
Nrd1 and Sen1 are differentially distributed on protein-
coding genes
Nrd1, Nab3, and Sen1 also bind to RNA sequences derived
from protein-coding genes. Cross-linked sequence reads were
sorted into ten bins covering each coding region in order to display
genes of different length on the same scale. Figure 4A–4C shows
the distribution of Nrd1 plus-strand and minus-strand reads on
genes ranked by expression level. Figure 4D–4F shows a similar
distribution of Sen1 reads. Highly expressed genes have a peak of
Nrd1 sense-strand reads derived from the 59 end. Genes with the
lowest level of expression show a peak of Nrd1 cross-linked
antisense reads at the 39 end. For Sen1 we observe the largest
number of reads on the 39 end of the most abundantly transcribed
genes.
Nrd1 binding to the 59 end of protein-coding transcripts
Nrd1 has been implicated in several regulatory mechanisms
involving binding to sequences in the 59 end of transcripts.
Figure 1. Transcriptome and chromatin mapping of Nrd1, Nab3, and Pol II on a segment of chromosome X. The top two panels depict
the position of Pol II. The bottom two panels show the position of Nrd1 and the middle panel depicts Nab3. The top and bottom panels represent
chromatin immunoprecipitation data for Rpb3 [63] and Nrd1 expressed as log2 IP/input, while the middle three panels represent RNA cross-linked to
Rpb2, Nrd1 and Nab3 expressed as reads per 10
7 reads in the respective data sets. The scale for Nrd1 and Nab3 PAR-CLIP has been set to 500610
7 to
emphasize the lack of PAR-CLIP reads at RPS5. The peak of reads (610
7) for Nrd1 and Nab3 on snR3 transcripts is 3,000 and 7,000, respectively. The
coordinates and positions of genes on chromosome X are shown at the bottom.
doi:10.1371/journal.pgen.1002329.g001
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Another form of regulation involving Nrd1 and Nab3 binding
near the 59 end of transcripts is alternative transcription start site
(TSS) selection on genes involved in nucleotide biosynthesis.
IMD2, URA2, URA8 and ADE12 have been shown to use
alternative transcription start sites (TSSs) in response to nucleotide
availability. For IMD2 and URA2 the upstream starts used in the
presence of sufficient NTP result in the elongation complex
passing through a Nrd1-Nab3 terminator thus reducing transcrip-
tion of mRNA [12,13,15]. We observe peaks of Nrd1 binding on
all of these transcripts (not shown). In addition, we see similar
binding on other genes involved in nucleotide metabolism
including HPT1, GUA1 and ADE17 (Figure S4). For each of these
genes multiple TSSs have been reported and are located upstream
and downstream of the Nrd1-Nab3 binding region, consistent with
regulation by TSS selection.
Figure 5 shows two additional genes, PCF11 and RPB10 that
have 59 Nrd1 binding peaks. In each case the peak of binding is
downstream of at least one mRNA 59 end suggesting that the gene
may be regulated by premature termination. Increased levels of
RNA from cells in which Nrd1 levels were depleted confirm that
PCF11 and RPB10 are negatively regulated by Nrd1 (Figure 5C
and 5D). In the case of PCF11 this regulation is particularly
interesting because PCF11 encodes a protein with a similar
termination function to Nrd1. While Pcf11 has primarily been
associated with termination of mRNAs it also plays a role in
termination of non-poly(A) transcripts [30,35]. Nrd1 and Pcf11
have been proposed to compete for recruitment to the transcrip-
tion complex [36,37] and the ability of Nrd1 to regulate Pcf11
expression may play a role in balancing this competition. For
example, conditions that reduce Nrd1 protein levels would be
expected to lead to compensatory increases in both NRD1 and
PCF11 expression. Nrd1 binding also regulates expression of
RPB10, a gene encoding an RNA polymerase subunit that is
common to all three nuclear RNA polymerases. This observation
suggests a possible role for the Nrd1 pathway in regulating
expression of the transcription machinery.
Nrd1 binds to antisense transcripts at the 39 end of
coding regions
In addition to sense-strand binding, we observe a large number
of Nrd1 reads derived from RNAs that are anti-sense to annotated
genes. Figure 4 shows that these reads are concentrated at the 39
end of genes that are not heavily transcribed in the sense direction.
Figure 6 shows Nrd1 and Rpb2 binding to antisense transcripts at
the 39 ends of the YKL151C and USA1 genes. We do not observe
abundant Sen1 cross-linking to the antisense transcript despite the
fact that it cross-links efficiently to the sense transcript of the
downstream gene. In Figure S5 we show that YKL151C encodes a
39 antisense CUT. We think it is quite likely that these antisense
transcripts originate from divergent transcription from the
downstream promoters [32,33] and may be involved in suppress-
ing transcription in the sense direction of YKL151C and USA1.
Sen1 binds to the 39 end of mRNA transcripts
Our cross-linking experiments show that Sen1 cross-links to
abundantly transcribed mRNAs. In Figure 7E we show examples
of Sen1 binding to transcripts derived from the heavily transcribed
RPL28, RPS13, RPL30 and PMA1 genes. Several arguments
suggest that this Sen1 cross-linking occurs on nascent transcripts.
First, Sen1 and Rpb2 both cross-link in clusters that are spaced
along the transcript in coincident peaks. A similar clustering of Pol
II-associated RNA has recently been attributed to pausing of Pol II
as nucleosomes are removed from the path of the elongating
polymerase [38]. Such clustering would not be expected on mature
transcripts. Second, although upstream cross-links are less abundant
on ribosomal gene transcripts, there is some cross-linking to intron
sequences that are enriched on nascent transcripts. Taken together,
these results suggest preferential binding to nascent RNA but we
cannot rule out binding to unprocessed precursors that have been
terminated and released from the template.
We note that Sen1 peaks are stronger toward the 39 end,
especially on the ribosomal protein transcripts. This is confirmed
in Figure 7D by plotting all Sen1 and Rpb2 reads with respect to
the 39 end of transcripts derived from the most heavily transcribed
genes [39]. Interestingly, the peak of Sen1 is broadly distributed
over the 75 nt before the polyadenylation site (pA) with few if any
reads extending beyond this cleavage site. In Figure 8 we show
that this downstream Sen1 cross-linking peak does not correspond
to Nrd1 or Nab3 cross-linking sites. A distinct peak of Pol II is
Figure 2. Conserved Nrd1 and Nab3 binding motifs. (A)
Sequence Logos of Nrd1 and Nab3 cross-linking sites generated from
MEME analysis of the top 277 cross-linked sites for Nab3 and the top
271 cross-linked sites for Nrd1. MEME conditions were set to discover
zero or one motif per sequence with a minimum number of sites set to
100 and the width to eight nucleotides. (B) Histogram showing the
distribution of T to C transitions plotted with respect to the top 50 Nrd1
cross-linking sites anchored to the zero position on the X axis.
doi:10.1371/journal.pgen.1002329.g002
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Clearly, Pol II continues to transcribe beyond the pA site but we
see little evidence for Pol II more than a few hundred bases further
downstream (Figure 7E).
In Figure 8 we have also compared our Rpb2 cross-linking data
set with the Net-seq data set derived from RNA non-covalently
associated with affinity purified Pol II [38]. While we see a very
similar pattern of reads within coding regions, we notice a
difference in the pattern of Pol II downstream of the pA site. The
downstream peak of Pol II that we observe in our PAR-CLIP data
is often missing in the Net-seq data (Figure 8).
Discussion
Nrd1, Nab3 and Sen1 have been shown to form a complex with
Pol II [3] and to direct the termination and subsequent processing
of nascent transcripts [16,40]. We have used an in vivo cross-
linking approach [18] to map the positions of these yeast RNA-
binding proteins in living cells. Our protocol maps Nrd1 and Nab3
binding sites to downstream snoRNA sequences that have
previously been shown to direct termination in vivo
[7,8,10,16,41] thus validating our procedure. These downstream
sequences are rapidly processed by the nuclear exosome [42,43]
indicating that cross-linking of Nrd1 and Nab3 occurs preferen-
tially on nascent transcripts.
The observation that Nrd1 ChIPs to chromatin at highly
expressed genes but only cross-links to a sub-set of these
transcripts (Figure 1) is consistent with a model in which Nrd1,
Nab3, and Sen1 enter the early Pol II elongation complex by
association with the Ser5 phosphorylated CTD [4,6]. This
association places Nrd1 and Nab3 in position to monitor the
nascent transcript for suitable RNA binding sites. The presence of
Spt5 in the Nrd1-Nab3-Sen1 complex [3] suggests a possible role
for Nrd1 and Nab3 in an early transcription elongation
checkpoint that controls the transition between early inefficient
elongation and the processive elongation that characterizes many
Pol II genes [1,2]. Nrd1 and Nab3 binding to the nascent
transcript could help slow elongation until all components of the
elongation complex are assembled.
This early elongation checkpoint may serve as a regulatory step
and several yeast genes including NRD1, IMD2, URA2, and SER3
contain Nrd1-bound RNAs derived from early elongation
complexes. We provide evidence here that several additional
genes can be added to this list including PCF11 and RPB10
(Figure 5); HPT1, GUA1 and ADE17 (Figure S4); and DIP5, LSR1,
RSF1, SWI5, and MEP1 (not shown). Data about the transcription
start site(s) of these genes is limited leaving open the question of
whether these genes are regulated by premature termination [11],
alternative start site selection [12,13,15], or promoter occlusion by
an upstream ncRNA [44].
Figure 3. PAR-CLIP plots for Nrd1, Rpb2, and Sen1. (A) and (B) Binding to snoRNA genes SNR3 and SNR13. (C) and (D) Binding to protein coding
genes NRD1 and CCW12. Pre-mRNA transcription start-sites are indicated by arrows on the gene map. The Nrd1 scale is set to 600 reads/10
7 to
emphasize minor peaks. Full-scale peaks for Nrd1 on SNR3 and SNR13 are 5,000 reads/10
7 and for the NRD1 gene is 2,500 reads/10
7.
doi:10.1371/journal.pgen.1002329.g003
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Another unexpected observation is that many poorly expressed
protein-coding genes express Nrd1-bound 39 antisense sequences.
Previous studies in yeast have identified regulatory antisense
transcripts for IME4, PHO5, PHO84 and the Ty1 retrotransposon
[45–49]. In the case of PHO84 and Ty1, antisense transcripts
appear to act in trans [47,49], although in the case of PHO84 cis-
suppression is also observed [48]. In Figure 6 we show several
genes with Nrd1 cross-linked anti-sense RNA peaks localized to
the 39 coding region. In each case the gene exhibiting 39 antisense
transcripts is poorly transcribed in the sense direction as
determined by RNA sequencing [39] and the downstream gene
is highly expressed in glucose-containing media [50]. These
antisense transcripts likely result from bi-directional transcription
from the downstream promoter [32,33]. The Rpd3s histone
deacetylase complex has been shown to repress antisense initiation
at many promoters [38] and it is possible that the Nrd1-Nab3 non-
poly(A) termination pathway prevents elongation of those anti-
sense transcripts that lack or escape Rpd3s control. The question
of whether these antisense transcripts are regulatory remains to be
answered, but we note that each of these Nrd1 antisense peaks
correlates with Rpb2 cross-linking sites but does not show efficient
Sen1 binding. We propose that Nrd1 pauses Pol II at these sites,
preventing sense strand transcription either through transcription
interference or by establishment of chromatin marks that are
inappropriate for transcription of the sense strand.
Sen1 binding
The distribution of Sen1 is surprising on two counts. First, we
failed to observe efficient cross-linking on some transcripts that
had previously been shown to depend on Sen1 function for proper
termination. SNR13 transcripts normally terminate just down-
stream of the Nrd1 binding site but in a sen1 mutant Pol II reads
through into the downstream TRS31 gene [16] and Sen1 ChIPs to
this downstream region [31]. Similarly, Nrd1 autoregulation is
disrupted in a sen1 mutant with steady-state levels of Nrd1 mRNA
increasing about 10-fold [11,16]. The failure of Sen1 to efficiently
crosslink to these transcripts can be explained in several ways.
Figure 4. Gene-averaged positive and negative strand Nrd1 and Sen1 cross-linked reads on genes ranked by expression level. (A–C)
Nrd1. (D–F) Sen1. High transcription and low transcription are the top and bottom quartiles as determined by RNA sequencing [39]. Medium
transcription represents the middle half of yeast genes ranked by expression level. Cross-linked RNA reads from the positive strand (above) and
negative strand (below) were sorted into ten fractionally equal coding-region segments (indicated by boxes) and 50 bp segments for the 59 and 39
UTRs. Lighter shading is used to indicate the difference between scaled reads derived from coding regions and unscaled reads from the UTRs.
doi:10.1371/journal.pgen.1002329.g004
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that prevents close apposition of Sen1 amino acid side chains with
4SU residues in the bound RNA. A second possibility is that Sen1
may play a structural role, stabilizing the Nrd1-Nab3-Sen1
complex in a manner that does not require the helicase activity.
In this model the sen1 mutation may alter the structure of the
complex leading to disruption of Nrd1 and/or Nab3 termination
function. A third possibility is that Sen1 may be required for
expression of another factor that is required for termination of
non-poly(A) transcripts. Finally, the low amount of Sen1 cross-
linking may indicate that low levels of Sen1 are sufficient for
proper termination at some genes. Future experiments must be
directed at understanding the role of Sen1 in termination of
snoRNA and attenuated Pol II transcipts.
Figure 6. Antisense transcripts on genes that are poorly expressed. In each panel the downstream gene expresses an antisense transcript
cross-linked to Nrd1 (blue) and Rpb2 (purple). Sen1 (green) cross-links poorly to the downstream antisense transcripts but cross-links to the upstream
sense transcripts. In each panel the sense reads are above the midline and negative strand reads are below as indicated by the negative reads per 10
7
on the Y axis.
doi:10.1371/journal.pgen.1002329.g006
Figure 5. Nrd1 regulation by binding in the 59 UTR. (A and B) Nrd1 cross-linking to the 59 UTR of PCF11 and RPB10. The sequence below each
plot shows the Nrd1 (blue arrow) and Nab3 (red arrows) cross-linking sites. Transcription start sites are indicated by black arrows. (C) Northern Blot for
PCF11 and RPB10 transcripts derived from wild-type cells or cells in which Nrd1 expression is regulated by a Tet promoter [62]. Cells were grown in
the presence of doxycycline. (D) Quantitative RT-PCR of RPB10 and PCF11 RNA derived from wild-type cells or cells in which Nrd1 expression is
regulated by a Tet promoter [64]. Cells were grown in the presence of doxycycline. The relative abundance of each target transcript is normalized to
the abundance of ACT1 and 18S rRNA in the same sample.
doi:10.1371/journal.pgen.1002329.g005
Yeast RNA-Binding Termination Factors
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is the widespread distribution of Sen1 on mRNA transcripts. A
role for Sen1 in mRNA 39 end formation has been suggested by
previous experiments. Sen1 interacts with Glc7, a protein
phosphatase that is part of the CPF complex [51,52]. In addition,
sen1 mutants display a weak read through phenotype on some pA
Figure 7. Distribution of Rpb2 and Sen1 on highly expressed genes. (A–D) Rpb2 and Sen1 reads distributed on transcripts from the RPL28,
RPS13, RPL30 and PMA1 genes. The position of polyadenylation sites [39] is indicated by a red arrow. (E) Distribution of reads averaged over the top
quartile of genes ranked by expression level. The X axis values are determined relative to the polyadenylation site [39]. Rpb2 reads are plotted in
purple and Sen1 reads in green.
doi:10.1371/journal.pgen.1002329.g007
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wide survey of Pol II distribution in a sen1-E1597K mutant did not
detect widespread read through of pA terminators [31] some read
through was observed and our data shows that several of those
genes including RPL43B, RPS28A, RPL36B, and SOD1 display
prominent Sen1 binding near their pA site (not shown).
Our data shows that Sen1 cross-linking occurs all along mRNA
transcripts, peaking at the 39 end (Figure 7). Sen1 interacts with
the Pol II CTD [5] but whether this interaction is direct is not
known. Based on the increased cross-linking toward the 39 end of
genes it is possible that Sen1 interacts with the Ser2 phosphor-
ylated form of Pol II or another protein that binds to this
phosphorylated form of the CTD.
The failure of Sen1 to cross-link downstream of the pA site
would seem to rule out a rho-like termination model in which
Sen1 translocates along the transcript facilitating termination upon
reaching the paused downstream Pol II. Recently Mischo et al.
[54] have shown that Sen1 helicase activity is required to remove
R loops that form at the 39 end of some transcripts. This proposal
is based in part on the identification of DNA:RNA hybrids
downstream of the pA site [54]. Sen1 helicase activity could
act to remove RNA from the DNA:RNA hybrid and expose
RNA downstream of the pA site for degradation by the 59-39
exonuclease Rat1. Our data argue, however, that Sen1 acts
upstream but not downstream of the pA site. We can clearly
observe cross-linked Pol II downstream of the pA site but there is
no corresponding Sen1 cross-linking in this region. Sen1 could act
upstream of the cleavage site to remove RNA from R loops and
allow access of the cleavage/polyadenylation machinery and
subsequently the 59-39 exonuclease Rat1. This model is consistent
Figure 8. Nab3, Nrd1, Rpb2, Rpb3, and Sen1 reads distributed on a variety of genes. The missing peak of Pol II downstream of the pA sites
in the NET-seq Rpb3 data [38] is indicated by an asterisk and the position of the pA site by an arrow.
doi:10.1371/journal.pgen.1002329.g008
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rat1 mutations [53,55].
Our data also suggest that the downstream peak of Pol II
represents the Pol II termination complex. Kinetic modeling of
yeast Pol II transcription suggests a termination time of about one
minute [56]. This is greater than the amount of time needed to
transcribe many yeast genes, suggesting that termination is the
rate-limiting step for formation of some mRNAs. We suggest that
the peak of Rpb2 cross-linking we observe downstream of the pA
site of heavily transcribed genes (Figure 7) represents this rate-
limiting Pol II elongation complex that is in the act of terminating.
We note that this downstream peak of Pol II is not as prominent in
the NET-seq data (Figure 8; [38]). The NET-seq data is obtained
by affinity purifying Pol II elongation complexes from chromatin
after digestion with DNase I. We propose that the downstream
termination complex is sensitive to DNase I digestion because of
an allosteric change that takes place as the elongation complex
passes through the pA site [57]. Thus, the RNA is lost from these
complexes and is under-represented in the NET-seq data.
Materials and Methods
Yeast strains
The genomic NRD1, NAB3, SEN1 and RPB2 genes in BY4733
were tagged with both 6His and biotin tags (HTB) [19]. The resulting
strains expressed proteins with a slightly higher molecular weight that
could be enriched on streptavidin beads (Figure S6). These strains
displayed no abnormal growth phenotypes. A TAP-tagged NRD1
yeast strain was used for chromatin immunoprecipitation.
Cell growth and UV 365 nm cross-linking
For the first two data sets, yeast cells expressing HTB tagged
Nrd1 or Nab3 were grown at 30uC in 2 L of synthetic complete
(SC-URA) medium supplemented with 2% dextrose, 120 mM
Uracil, 0.01 mM Biotin from OD600,0.1 to mid-exponential phase
(OD600,0.5). 4SU was added to a final concentration of 300 mM
and growth continued at 30uC until OD600,1.5. Addition of 4SU
had no effect on the growth rate of yeast during the time course of
the experiment. Cells were harvested by centrifugation and the cell
pellet was re-suspended in 60 ml of ice-cold water, separated into
two 30 ml aliquots and placed in 145620 mm sterile tissue culture
dishes kept on ice. Cells were irradiated on ice with 365 nm UV
light(0.15 J/cm
2) ina Stratalinker2400 (Stratagene),three timesfor
10 minutes each with shaking between irradiations. Cells were
pooled, centrifuged, and the cell pellet was re-suspended in 5 ml of
buffer-1 (8 M urea, 300 mM NaCl, 0.5% Nonidet P-40, 50 mM
sodium phosphate, 50 mM Tris-HCl, pH 8.0, and EDTA-free
protease inhibitor mix for His-Tag sequences (RPI)) then frozen in
droplets in liquid nitrogen. Cell droplets were kept in 280uC until
processed as described below.
In the analysis of the initial Nrd1 and Nab3 data sets we
observed binding to a number of RNAs derived from stress-
induced genes. The RNA in these early experiments was obtained
from cells that were irradiated after centrifugation and re-
suspension in ice-cold water [21], a procedure that is likely to
induce a stress response. To eliminate this possibility we developed
a second technique to irradiate cells growing in liquid media at
30uC. Two liters of growing cells were placed in a two-liter beaker
on a magnetic stirrer and irradiated from a distance of 10 cm for
10 min with a UV Power–Shot 1100 Lamp. This lamp delivers
1 W/cm
2 primarily in the in the 300–400 nM range with a peak
at 365 nm. To eliminate shorter wavelength light the beaker was
covered with a Pyrex baking dish. Cells irradiated in this manner
were processed as described below.
Protein–RNA purification
Protein purification was based on a previously published
protocol [58]. Cell droplets were lysed in liquid nitrogen using a
Spex SamplePrep 6870 freezer mill with 10 cycles of one minute of
breakage and two minutes of cooling, at a frequency setting of 15
cps. Lysates were thawed at room temperature, resuspended in
5 ml of buffer-1 then sonicated using a 1/80 microprobe tip of
Branson sonifer cell disruptor Model 250/450. Sonication was
performed three times at 50% power for 5 seconds with 30 second
intervals at room temperature. Cell lysates were cleared by
centrifugation at 40,000 rpm in Beckman L-80 ultracentrifuge at
room temperature for 30 minutes using Ti 70.1 rotor. Cleared
lysates were incubated with Ni-NTA agarose (QIAGEN, 500 ml
slurry pre-equilibrated in buffer-1) for 3 hours at room temper-
ature. Ni-NTA agarose was then washed in 5 ml of buffer-1; 5 ml
of buffer-1, pH 6.3; and 5 ml of buffer-1, pH 6.3, +10 mM
imidazole. Proteins were eluted in 8 ml of buffer-2 (8 M urea,
200 mM NaCl, 2% SDS, 50 mM sodium phosphate, 10 mM
EDTA, 100 mM Tris-HCl, pH 4.3, and EDTA-free protease
inhibitor mix for His-Tag sequences (RPI)). The pH of the eluate
was neutralized and loaded onto streptavidin magnetic beads (New
England Biolabs). A 200 ml slurry of beads was pre-equilibrated in
buffer-3 (8 M urea, 200 mM NaCl, 0.2% SDS, 100 mM Tris-
HCl, pH 8.0, and EDTA-free protease inhibitor mix for His-Tag
sequences). After incubation overnight at room temperature the
streptavidin magnetic beads were washed in 36500 ml of buffer-3,
36500 ml of buffer-3 with 2% SDS, 36500 ml of buffer-3 without
SDS, and then 36500 ml of T1 ribonuclease buffer (150 mM KCl,
2 mM EDTA, 0.5 mM DTT, 50 mM Tris-HCl, pH 7.4, and
EDTA-free protease inhibitor mix for His-Tag sequences (RPI
Crop.)). The streptavidin magnetic beads were resuspended in
0.5 ml of T1 buffer before RNase T1 (Fermentas) was added to
obtain a final concentration of 40 U/ml and the bead suspension
was incubated at room temperature for 15 minutes. Beads were
washed three times with 500 ml of T1 wash buffer (500 mM KCl,
0.05% NP40, 0.5 mM DTT, 50 mM Tris-HCl, pH 7.8, and
EDTA-free protease inhibitor mix for His-Tag sequences (RPI
Corp.)) and three times with 500 ml of polynucleotide kinase
(PNK) buffer (50 mM NaCl, 10 mM MgCl2, 5 mM DTT, 50 mM
Tris-HCl, pH 7.4, and EDTA-free protease inhibitor mix for His-
Tag sequences). Beads were resuspended in 160 ml of PNK buffer
before Thermosensitive Alkaline Phosphate (TSAP) (Promega) was
added to obtain a final concentration of 0.15 U/ml, and Super-
RNase inhibitor (Ambion) was added to obtain a final concentra-
tion of 1 U/ml. The bead suspension was incubated for 30 minutes
at 37uC then was washed once with 500 ml of buffer-3 without
SDS, and 3 times with 500 ml of PNK buffer.
cDNA library construction from crosslinked RNA
Streptavidin magnetic beads from the previous step were
resuspended in 200 ml of PNK buffer then c-
32P-ATP (MP
Biomedicals) was added to obtain a final concentration of 0.5 mCi/
ml and T4 PNK (New England Biolabs) was added to obtain a final
concentration of 1 U/ml. The bead suspension was incubated at
37uC for 30 minutes before non-radioactive ATP was added to
obtain a final concentration of 100 mM, the incubation was
continued for 10 minutes at 37uC. The bead suspension was
washed 4 times with 650 ml of T4 RNA Ligase2 truncated (Rnl2
(1–249)) buffer (2 mM MgCl2, 1 mM DTT, 50 mM Tris-HCl,
pH 7.5) (New England Biolabs).
Streptavidin magnetic beads from the previous step were
resuspended in 19 ml of Rnl2 (1–249) buffer combined with
19 ml of 50% Polyethylene Glycol 8000 (PEG 8000) (Promega).
To the bead suspension was added 2 ml of 100 mM adenylated
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CTTCTGCTTGTC; IDT), 0.4 ml of 1 M MgCl2, 2.5 ml of Rnl2
(1–249) (200 U/ml) (New England Biolabs), 1.25 ml of RNase
inhibitor (40 U/ml) (Invitrogen). The bead suspension was
incubated at room temperature for 4 hours then washed once
with 500 ml of buffer-3 without SDS, and 3 times with 500 mlo f
PNK buffer. The washed streptavidin magnetic beads were re-
suspended in 38 ml of PNK buffer, then to the bead suspension
was added 2 ml 100 mM5 9 adapter oligonucleotide (GUUCAGA-
GUUCUACAGUCCGACGAUC), 1.25 ml of RNase inhibitor
(40 U/ml), 2.5 ml of T4 RNA ligase (10 U/ml) (Fermentas), 3 mlo f
10 mM ATP (New England Biolabs). The bead suspension was
incubated overnight at 16uC then washed once with 500 mlo f
buffer-3 without SDS, and 3 times with 500 ml of Protease K
buffer (75 mM NaCl, 6.25 mM EDTA, 1% SDS, 50 mM Tris-
HCl, pH 7.5). The streptavidin magnetic beads were resuspended
in 200 ml of protease K buffer follow by the addition of Protease
K (Ambion) to the final concentration of 1.2 mg/ml. After
incubation at 55uC for 30 minutes, the supernatant was trans-
ferred to a new tube and another 200 ml of protease K buffer was
added to the streptavidin magnetic beads. The incubation was
continued for 5 minutes at 55uC before the supernatant was
combined and the RNA was recovered by acidic phenol/
chloroform extraction followed by a chloroform extraction and
an ethanol precipitation. The pellet was dried and then dissolved
in 12 ml of DPEC water. The recovered RNA was divided into
364 ml aliquots and kept in 280uC until further preparation.
The recovered RNA was used to synthesize a cDNA library.
Time course PCR amplification was performed in order to
determine the optimum number of cycles for amplifying the cDNA
library. One aliquot of recovered RNA was taken out of 280uCt o
thaw on ice, then reverse transcription oligonucleotide (CAAG-
CAGAAGACGGCATACGA) was added to the final concentra-
tion of 5 mM. The mixture was briefly centrifuged, heated at 70uC
on a preset thermal cycler for 2 minutes and the tube was then
placed on ice. To the iced tube containing the primer-annealed
template RNA was added 4 ml of the premixed reverse
transcription reaction mixture containing 2 ml of 5 X first strand
buffer (375 mM KCl, 15 mM MgCl2, 250 mM Tris-HCL,
pH 8.3) (Invitrogen), 0.5 ml of 12.5 mM dNTP mix (Fermentas),
1 ml of 0.1 M DTT (Invitrogen), and 0.5 ml of RNase inhibitor
(40 U/ml) (Invitrogen). The tube was heated on the preset thermal
cycler at 48uC for 3 minutes then Superscript II reverse
transcriptase (Invitrogen) was added to the final concentration of
20 U/ml, the incubation was continued for 1 hour on the preset
thermal cycler at 44uC. Time course PCR was carried out on a
50 ml scale using cDNA from the previous step and Phusion DNA
polymerase (Finnzymes) (10 ml of the cDNA, 0.5 mlo f2 5m M
dNTP Mix, 10 ml of 5 x Phusion HF buffer (Finnzymes), 1 mlo f
100 mM primers, 0.5 mlo f2U / ml Phusion DNA polymerase).
PCR cycle conditions of 10 s at 98uC, 30 s at 60uC, 15 s at 72uC
were used. Aliquots of 6 ml were removed every other cycle
starting with cycle number 14 by temporarily pausing the PCR
cycle at the end of the 72uC step. The maximum cycle of the PCR
was set at 30 cycles. PCR aliquots were analyzed on a 6% Novex
TBE PAGE gel (Invitrogen) and the optimal cycle number for
cDNA amplification was chosen as five cycles prior to reaching the
saturation level of PCR amplification. The optimal cycle number
PCR was performed on a 50 ml scale using cDNA prepared from
another aliquot of recovered RNA (4 ml). The amplified cDNA
product was separated on a 6% Novex TBE PAGE gel
(Invitrogen) and the band of interest was excised and eluted using
1 x gel elution buffer (Illumina). RNA fragments with both
adapters produce PCR fragments that span a range of 100–150 nt.
The 59-adapter-39-adapter products without inserts may be
detected after amplification of the cDNA as an additional PCR
band at around 75 nt in length. The eluted DNA from gel
extraction was ethanol precipitated followed by DNA analysis
using Agilent 2100 Bioanalyzer. DNA was sequenced using an
Illumina GAII sequencer (University of California, Riverside).
Bioinformatic analysis
Sequences were trimmed using the function trimLRPatterns
from the ShortRead package in Bioconductor [59]. Reads were
aligned to the Sacchromyces cerevisiae genome using the short read
aligner Bowtie [60]. The bowtie alignment allowed the read to
have up to 1 mismatch and align once to the genome. Reads that
aligned more than once to the genome will be discussed elsewhere
[22]. All figures were made using the Mochiview genome browser
[29]. The processed wig files for each dataset, along with fasta file
of the yeast genome for alignment, can be downloaded from Gene
Expression Omnibus [61] under the series number GSE31764
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31764).
Chromatin immunoprecipitation
Cells containing a TAP-tagged NRD1 gene were grown in yeast
extract peptone dextrose (YPD) to an absorbance of about 0.8 and
cross-linked with formaldehyde for 20 min at room temperature
and processed for chromatin immunoprecipitation according to
standard protocols [62]. ChIP and Input DNA were first amplified
using linker adapted random primer and sequenase 2 and further
amplified and labeled using PCR and Cy3- and Cy5- CTP,
respectively. Cy dye labeled ChIP and Input DNA was combined
with Agilent aCGH/ChIP hybridization buffer containing 2x Hi-
RPM Hyb Buffer, Agilent blocking agent and Human cot-1 DNA
and hybridized to Agilent 244K yeast tiling array (G4491A) for
40 hours on MAUI hybridization system with constant mixing.
The hybridized array was washed using Agilent aCGH/ChIP-on-
chip array washing buffer kit (5188–5266) and scanned on Axon
GenePix Scanner (GenePix A4300) and the raw data extracted
using GenePix Pro 6.0. Preliminary analysis of the ChIP data was
carried out using CisGenome to identify ChIP enriched regions.
Yeast RNA analysis
Total RNA was extracted from yeast with hot acid phenol and
run on a 1% denaturing formaldehyde MOPS agarose gel,
visualized by ethidium bromide and Northern blotted as
previously described [11]. Samples with clear rRNA bands and
no visible degradation were analyzed by quantitative real-time
RT-PCR. RNA was treated with turbo-DNA-free (Ambion)
according to the manufacturer’s instructions for the most stringent
treatment. Reverse transcription was performed using the iScript
cDNA Synthesis Kit (BioRad). Real-time PCR was performed in
triplicate 20 ml reactions on a CFX96 Real-time PCR detection
system (BioRad) using iQ SYBR green supermix (BioRad)
according to the manufacturer’s instructions. Data from at least
two replicate experiments were pooled using the Gene Study
feature of the CFX96 real-time software, which normalizes for
fluorescence intensity differences between plates. Expression was
normalized to both ACT1 and 18S ribosomal RNA and the ratios
were graphed relative to the wild-type control sample, which was
set to 1 for each gene. Error bars represent the positive and
negative range of the standard error of the mean.
Treatment of tet-promoter strains
Tet-promoter yeast strains (Open Biosystems) and a control
strain lacking a tet-responsive promoter were seeded to an initial
Yeast RNA-Binding Termination Factors
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to the addition of doxycycline at a final concentration of 10 mg/ml
and were grown an additional five hrs before collection.
Supporting Information
Figure S1 Distribution of Nrd1 and Nab3 cross-links on snR13
and Nrd1 transcripts. (A) Nab3 (red) and Nrd1 (blue) reads are
aligned to the region downstream of the SNR13 gene. The
sequence corresponding to the main peak is shown below the plot
with an arrow indicating the most frequently cross-linked base.
Nrd1 and Nab3 binding motifs identified in our earlier genetic
selection are indicated above the transcript and the arrow
indicates the most frequent T to C transition. (B) Nrd1 and
Nab3 reads aligned to the Nrd1 gene. This binding region
correlates with earlier work showing that sequences upstream of
and including the 59 part of the coding region are necessary for
autoregulation of Nrd1 expression.
(EPS)
Figure S2 Cross-linking of Nrd1, Rpb2 and Sen1 to the IMD2
gene. The transcription start site is indicated by an arrow on the
gene map.
(EPS)
Figure S3 Cross-linking of Sen1, Rpb2, Nab3 and Nrd1 to
selected CUTs and SUTs. (A) Cross-linking to NEL025c, the
original CUT (SUT?) [34] (B and C) Cross-linking to CUTs
described in [9]. Note that the antisense CUT in the 39 end of
FMP40 is not annotated in the Steinmetz or Jacquier databases
[31,32]. (D and E) Cross-linking to some CUTs but not others. In
each of these figures there is one CUT cross-linked while another
is not. This is also observed in A and B. (F) Highly expressed
CUT585 cross-links efficiently to Nrd1 and Nab3 but not Sen1.
(EPS)
Figure S4 Binding of Nrd1 to the upstream regions of genes
involved in nucletide metabolism. (A) GUA1 encoding GMP
synthase. (B) ADE17 encoding both 5-aminoimidazole-4-carbox-
amide ribonucleotide transformylase and inosine monophosphate
cyclohydrolase activities. (C) HPT1 encoding hypoxanthine-
guanine phosphoribosyltransferase.
(EPS)
Figure S5 NRD1-dependent termination of a transcript anti-
sense to YKL151C. RNAs produced in strains with wild-type
NRD1 (NRD1HA) or mutant nrd1 (nrd1-102HA) with and without
the deletion of the exosome gene RRP47 were probed with a radio-
labeled T7 transcript complimentary to the antisense RNA. SCR1
is probed as a loading control.
(EPS)
Figure S6 Western blot of proteins derived from tagged Nrd1,
Nab3, Rpb2 and Sen1 strains. (A) Protein extracts were run on
SDS-PAGE and transferred to nitrocellulose. Nrd1 (green) was
detected with a rabbit polyclonal antibody and Nab3 (red) with a
mouse monoclonal antibody. Secondary antibodies were labeled
with IR dyes and detected with a LiCor Odyssey scanner. (B)
Proteins in cell extracts were affinity purified on streptavidin
beads, eluted in SDS sample buffer, run on SDS PAGE, blotted
and probed with an anti-His-tag antibody anti-RGS(H)4, (Qiagen).
The asterisk indicates the position of the Rpb2 tagged protein.
Due to its low abundance or instability we were unable to observe
Sen1-HTB in extracts by Western Blot. (C) Silver stain of Sen1-
HTB purified on strepavidin beads.
(EPS)
Table S1 Distribution of sequence reads corresponding to
different classes of RNAs. The distribution of reads from five
different data sets is presented as both the number of reads and the
percentage of total reads. The data discussed in this publication
have been deposited in NCBI’s Gene Expression Omnibus [61] and
are accessible through GEO Series accession number GSE31764
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31764).
(DOC)
Table S2 The top 100 Nab3 cross-linked sites.
(XLSX)
Table S3 The top 100 Nrd1 cross-linked sites.
(XLSX)
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